News

As we battle the entwined epidemics of obesity and type 2 diabetes, exercise is an important tool at our disposal. In her Claude Bernard prize lecture at this year’s EASD conference, Professor Juleen Z...

Obesity is a risk factor for type 2 diabetes but it’s not universally the case that those who are diagnosed are overweight or obese. Two pieces of new research presented at the recent 57th EASD Annual ...

Findings presented at the 57th EASD Annual Meeting suggest that calcium dobesilate can prevent retinal damage by stopping capillary leakage. It may therefore be able to protect the eyesight of people with di...

The strong influence of genetics in type 2 diabetes is becoming increasingly apparent, thanks to advances in technology like next generation sequencing. In her Minkowski Prize Lecture at the 57th EASD Annual...

Webcasts from the EASD’s 2021 virtual meeting are now available free to all on the EASD website. To help you explore what’s on offer, over the coming weeks we’ll be giving you a taste of so...

Current technologies and hopes for the future were hot topics at October’s GAED Annual Virtual Congress.

A study presented at last month’s EASD Annual Meeting reveals that spinal cord stimulation is a safe and effective treatment for persistent pain caused by diabetic peripheral neuropathy. It also brings...

Regional nuances in the public health impact of inactivity and approaches to its treatment were in the spotlight at this year’s EASD Annual Meeting, as part of an ‘East meets West’ symposiu...

Diabetic foot ulcers (DFUs) can be prevented and involving the patient in their own footcare plays a large part in achieving that.

A new study from the Steno Diabetes Center, presented at last month’s EASD conference, shows the value of multifactorial intervention in type 2 diabetes. Improvement in more than one risk factor had a ...

Reporting at the EASD’s 57th Annual Meeting, a team at the Karolinska Institute has found that mental health issues like depression and anxiety affect not just the person with type 1 diabetes, but thei...

Psychosocial care and individualisation were common themes from the new ADA/EASD consensus report presented at the 57th EASD Annual Meeting 2021.

Researchers in Finland have used the latest genome-analysis technology to discover some rare gene variants that contribute to severe diabetic retinopathy.

It may be worth paying more attention to both degree of insulin resistance and fasting insulin levels when monitoring the health of people with type 2 diabetes, according to new research presented at the EAS...

A further analysis of the STEP 2 trial results presented at last week’s 57th EASD Annual Meeting showed promising glucose metabolism results for the GLP-1 receptor agonist, with two thirds of participa...

Results from the EMPEROR-Preserved trial give further testament to the benefits offered by SGLT-2 inhibitors in diabetes care.

The brain is a voracious consumer of glucose and for many the effects upon it of a lack of blood sugar are among the most concerning aspects of life with diabetes. For our latest ‘Long and short of it&...

The value attached to real-world evidence (RWE) in clinical decision making has increased significantly over recent years. Using examples taken from diabetes treatment, our latest module – launching to...

In his second module for our ‘Diabetic neuropathy’ course, Professor Solomon Tesfaye takes a closer look at the pathophysiology of diabetic peripheral neuropathy and surveys the treatments curren...

What happened when we asked our authors to list the top five research questions in their area of specialisation? The answer is a new series of short films, starting today.

The close link between obesity and type 2 diabetes is well established, but our latest module digs deeper – exploring the wider relationship with ethnicity, age and complications, cardiovascular diseas...